Patents by Inventor DORI C. WOODS

DORI C. WOODS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230193353
    Abstract: Disclosed are compositions and methods related to the use of plurality of reverse transcriptase primers, unique molecular identifiers (UMIs), and/or spiky primers with unique junction identifiers to improve the sequencing and amplifications methods. In some embodiments, the disclosed methods can identify sequencing errors and PCR-jumping errors.
    Type: Application
    Filed: May 7, 2021
    Publication date: June 22, 2023
    Inventors: Zoe Fleischmann, Konstantin Khrapko, Dori C. Woods, Jonathan L. Tilly
  • Patent number: 10525086
    Abstract: The present technology provides for methods for generation and isolation of granulosa cells and/or granulosa cell precursors from multi-potent cells, wherein the granulosa cells and/or granulosa cell precursors are useful in methods for growth and maturation of follicles or follicle-like structures. Additionally, the present technology also provides for methods of increasing steroidal hormones in a subject in need thereof.
    Type: Grant
    Filed: March 27, 2014
    Date of Patent: January 7, 2020
    Assignee: Northeastern University
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Publication number: 20190300850
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Application
    Filed: December 21, 2018
    Publication date: October 3, 2019
    Inventors: Jonathan Lee Tilly, Dori C. Woods
  • Publication number: 20160237402
    Abstract: The present technology provides for methods for the directed differentiation of multi-potent cells, female germ line stem cells, or oogonial stem cells into oocytes, granulosa cells and/or granulosa precursor cells, i.e.,“synthetic granulosa cells.” The synthetic granulosa cells are useful in methods for growth and maturation of follicles or follicle-like structures and immature oocytes. Additionally, the synthetic granulosa cells are useful in methods of increasing ovarian derived hormones and growth factors in a subject in need thereof.
    Type: Application
    Filed: October 7, 2014
    Publication date: August 18, 2016
    Inventors: Jonathan L. TILLY, Dori C. WOODS
  • Publication number: 20160208214
    Abstract: The present technology provides for a developmentally-incompetent egg cell that is produced by genetically engineering (e.g., inactivating) at least one gene in an oocyte precursor cell and culturing the oocyte precursor cell in conditions sufficient to produce an egg cell. The present technology also provides for methods of using the developmentally-incompetent egg cell.
    Type: Application
    Filed: October 2, 2014
    Publication date: July 21, 2016
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Publication number: 20150353887
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Application
    Filed: August 11, 2015
    Publication date: December 10, 2015
    Inventors: Jonathan Lee Tilly, Dori C. Woods
  • Patent number: 9150830
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Grant
    Filed: September 7, 2012
    Date of Patent: October 6, 2015
    Assignee: The General Hospital Corporation
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Patent number: 8647869
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Grant
    Filed: April 13, 2012
    Date of Patent: February 11, 2014
    Assignee: The General Hospital Corporation
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Patent number: 8642329
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Grant
    Filed: August 21, 2012
    Date of Patent: February 4, 2014
    Assignee: The General Hospital Corporation
    Inventors: Jonathan Lee Tilly, Dori C. Woods
  • Publication number: 20130060079
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Application
    Filed: August 21, 2012
    Publication date: March 7, 2013
    Applicant: The General Hospital Corporation
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Publication number: 20130052727
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Application
    Filed: September 7, 2012
    Publication date: February 28, 2013
    Applicant: The General Hospital Corporation
    Inventors: Jonathan L. Tilly, Dori C. Woods
  • Publication number: 20120315651
    Abstract: Oogonial stem cell (OSC)-derived compositions, such as nuclear free cytoplasm or isolated mitochondria, and uses of OSC-derived compositions in autologous fertility-enhancing procedures are described.
    Type: Application
    Filed: April 13, 2012
    Publication date: December 13, 2012
    Applicant: THE GENERAL HOSPITAL CORPORATION
    Inventors: JONATHAN L. TILLY, DORI C. WOODS